Björn Eliasson

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Aidin Rawshani, Araz Rawshani, Stefan Franzén et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Medicine, Endocrinology, Clinical Epidemiology +14

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

Nikolaus Marx, Massimo Federici, Katharina Schütt et al. · European Heart Journal · 2023 · 1.4K citations · Full text

Medicine, Cardiology, Endocrinology +17

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

Aidin Rawshani, Araz Rawshani, Stefan Franzén et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

Araz Rawshani, Naveed Sattar, Stefan Franzén et al. · The Lancet · 2018 · 792 citations · Full text

Medicine, Health Sciences, Internal Medicine +13